Aurinia Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 551-575 of 606 matching filings.

Per page
25
Current page
23
6-K File 001-36421

AURINIA PHARMACEUTICALS INC.

Filing date
18 Mar 2016
Reporting date
18 Mar 2016
Next action
Verify source filing
40-F File 001-36421

ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015

Filing date
18 Mar 2016
Reporting date
31 Dec 2015
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
02 Mar 2016
Reporting date
02 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
01 Mar 2016
Reporting date
29 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88628

SC 13G/A

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88628

SC 13G filing

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88628

SC 13G filing

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
11 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
08 Feb 2016
Reporting date
08 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
04 Feb 2016
Reporting date
04 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
02 Feb 2016
Reporting date
02 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
01 Feb 2016
Reporting date
29 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
19 Jan 2016
Reporting date
19 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
24 Nov 2015
Reporting date
24 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

FORM 6-K

Filing date
13 Nov 2015
Reporting date
13 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
13 Nov 2015
Reporting date
13 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-206994

EFFECT filing

Filing date
05 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
19 Oct 2015
Reporting date
19 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
F-10/A File 333-206994

AMENDMENT NO. 1 TO FORM F-10

Filing date
16 Oct 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
17 Sep 2015
Reporting date
17 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
F-X File 333-206994

F-X

Filing date
17 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-10 File 333-206994

REGISTRATION STATEMENT ON FORM F-10

Filing date
17 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
02 Sep 2015
Reporting date
02 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
11 Aug 2015
Reporting date
11 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

FORM 6-K

Filing date
11 Aug 2015
Reporting date
11 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .